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  28 
Abstract.  29 
Problem Complement is a central defence against sepsis and increasing complement 30 
insufficiency in neonates of greater prematurity may predispose to increased sepsis. 31 
Ureaplasma spp. are the most frequently cultured bacteria from preterm blood samples. 32 
Method of Study A sheep model of intrauterine Ureaplasma parvum infection was used to 33 
examine in vivo Ureaplasma bacteraemia at early and late gestational ages. Complement 34 
function and Ureaplasma killing assays were used to determine the correlation between 35 
complement potency and bactericidal activity of sera ex vivo. 36 
Results Ureaplasma were cultured from 50% of 95-day gestation lamb cord blood samples 37 
compared to 10% of 125-day gestation lambs. Bactericidal activity increased with increased 38 
gestational age and a direct correlation between functional complement activity and bactericidal 39 
activity (R2=0.86; p<0.001) was found for 95-day gestational lambs.   40 
Conclusions Ureaplasma bacteraemia in vivo was confined to early preterm lambs with low 41 
complement function, but Ureaplasma infection itself didn’t diminish complement levels. 42 
43 
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INTRODUCTION 44 
The complement system encompasses a series of >30 serum proteins that interact through an 45 
amplification cascade following activation by foreign microbial surfaces, immune complexes, 46 
surface-bound antibodies or pathogen-bound pattern recognition molecules. Like most 47 
elements of the innate immune system, the complement system does not require previous 48 
exposure to be effective.  Complement also acts to integrate the innate and humoral immune 49 
responses through recruiting innate and adaptive immune cells to the site of activation (via 50 
chemotaxin and anaphylotoxin release), improving the humoral response through a natural 51 
adjuvant activity, and increasing engulfment of microbes through decorating the surface with 52 
opsonins.1  Complement has direct anti-microbial activity mediated by the formation of lytic 53 
pores on activating surfaces, which makes it a pivotal barrier to initial invasion by pathogens.  54 
However, as we have previously reviewed, the complement system does not have full potency 55 
(for both activation and regulatory factors) at birth in humans due to lower circulating levels of 56 
some of the components and this insufficiency is greater with increasing prematurity.2 The 57 
reduced capacity of the complement system at term and birth, which is exacerbated with 58 
increasing prematurity, has been proposed to be responsible for the increased susceptibility of 59 
neonates to bacterial infection and sepsis.3  60 
 61 
Intrauterine infection by Ureaplasma parvum (UP) is strongly associated with preterm birth, 62 
and is among the organisms most commonly isolated from gestational tissues.4,5  UP is one of 63 
the smallest self-replicating microorganisms identified to date with a minimal genome (0.75-64 
0.78 Mbp) that limits it to a parasitic existence.6  Most notably, the UP genome does not encode 65 
any components that make up a cell wall, which is common to most bacteria and therefore 66 
inherently resistant to all classes of antibiotics that function by inhibiting cell wall synthesis.  67 
The cell wall also confers a protective effect against membrane attack complex-mediated 68 
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complement killing (particularly effective for Gram-positive bacteria), which may explain why 69 
UP is relatively susceptible to human complement.7 70 
 71 
Ureaplasma bacteraemia is detected in up to 23% of preterm cord blood samples4 and was 72 
isolated from blood samples in a cohort of 200 preterm neonates8, showing that this organism 73 
represents one of the most prevalent systemic infections in births under 32 weeks gestational 74 
age.  To determine if sheep could be used as an in vivo model to investigate the correlation of 75 
complement development and bacteraemia with increasing prematurity observed in humans, 76 
we have examined bacteraemia and complement function using a well-established experimental 77 
model for in utero UP infection.9-11  Here we investigate the ability of adult and preterm sheep 78 
sera to kill U. parvum in vitro, and investigate the presence of fetal U. parvum bacteraemia 79 
following experimental intrauterine infection in vivo. We hypothesised that, in a sheep model 80 
of pregnancy, the degree of gestation-dependent complement insufficiency in preterm lambs 81 
would correlate with fetal UP bacteraemia. To investigate this hypothesis, we examined: i) 82 
plasma titres of UP from lambs delivered at early- (95 d) and mid- (125 d) term gestations; ii) 83 
fetal anti-UP antibody responses; iii) UP killing activity of serum from adult sheep and preterm 84 
lambs; and iv) the kinetics and calcium dependence of serum UP killing activity. 85 
  86 
METHODS 87 
Animal Studies 88 
All experimental sheep procedures were performed in Perth, Australia following approval by 89 
the University of Western Australia Animal Ethics Committee (RA/3/100/1289).  37 date-mated 90 
merino-cross ewes (Ovis aries) carrying singleton pregnancies were separated into 5 groups.  91 
Two groups received a received a single intraamniotic (IA) injection of sterile saline (Group 1; 92 
controls; n=5) or 105 infectious units of UP at 80 d GA (Group 2; n=8), for delivery at 95 d 93 
GA. Three further groups received a single IA injection of sterile saline (Group 3; controls; 94 
  Kemp/Ahmed et al. 
5 
 
n=6) or 105 infectious units of UP at 70 (Group 4; n=8) or 115 d GA (Group 5; n=10) for 95 
delivery at 125 d GA.  Injections were carried out under ultrasound guidance as described 96 
previously.12 Maternal blood was collected into serum separator and EDTA plasma tubes by 97 
peripheral venepuncture prior to euthanasia with intravenous pentobarbitone (100mg/kg) at 98 
either 95 (Groups 1 and 2), or 125 d GA (Groups 3, 4 and 5). The fetus was surgically delivered 99 
under terminal anaesthesia. Fetal viability at time of euthanasia was confirmed by ultrasound 100 
cardiac imaging and by fetal arterial cord blood gas analysis (Table 1). Fetal amniotic fluid and 101 
arterial cord blood (both serum and plasma) were obtained during surgical delivery by aseptic 102 
technique to ensure no cross contamination. Samples for serum (and plasma) separation were 103 
immediately dispensed into serum separator tubes (Becton-Dickinson) and placed on ice.  104 
Serum was separated by centrifugation at 2500 xg for 20 minutes prior to immediate aliquoting 105 
into sterile tubes and transfer to -80oC until analysis.  Serum and plasma samples were processed 106 
in under 3 hours after collection (kept on ice at all intervals) until separation and freezing at -107 
80oC. UP levels in plasma and amniotic fluid were determined by culture in triplicate 108 
immediately upon delivery (on fresh samples, not frozen and thawed), as detailed below. 109 
Maternal blood samples for comparative complement function assays were collected from 110 
pregnant, UP-naïve ewes into serum separator tubes as above. 111 
 112 
Ureaplasma parvum culture and killing assay. 113 
The serovar 3 strain HPA5 of Ureaplasma parvum (UP)13 was used for all experiments.  UP 114 
was cultured using commercial Ureaplasma selective medium (USM; Mycoplasma experience 115 
ltd., Surrey, UK), using standard techniques as previously outlined.14  UP titres were quantified 116 
by serial 10-fold dilution (or 2-fold dilution for killing assay) in USM, in triplicate and 117 
incubated at 37oC for 48 h prior to recording results.  Killing assays were performed as for 118 
previous human serum studies,14 with the exception of experiments to determine the rate of 119 
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serum killing. For those experiments, 10mM EDTA (final concentration) was added to block 120 
further complement activation at defined incubation times and the serum removed by 121 
centrifugation and resuspension in USM prior to titration of surviving bacteria.  Transient 122 
exposure to EDTA was not found to alter growth of UP in separate experiments.  Serum killing 123 
was calculated as the fold decrease relative to the titration of surviving bacteria following 124 
identical exposure to the same sera, except that all complement activity had been removed by 125 
heat-inactivation at 56oC for 30 minutes prior to the experiment.  126 
 127 
Haemolysis assay 128 
Haemolysis assays were performed as previously published.15 Guinea pig erythrocytes were 129 
purchased from TCS Biosciences (Oxford, UK) and sensitised with rabbit polyclonal anti-130 
guinea pig erythrocyte antibodies purchased from Fitzgerald Industries International (North 131 
Acton, MA), as described previously.15  Sheep serum from pregnant ewes and their singleton 132 
lambs were obtained by peripheral venepuncture of Merino- cross ewes and fetal cord blood 133 
was obtained from their lambs during surgical delivery at 95 and 125 d GA.  Sera from both 134 
uninfected control and UP infected sheep were examined. Sera were stored at -80oC prior to 135 
use and aliquots only thawed once.    136 
 137 
IgG quantitation and anti-UP response 138 
IgG concentrations in all sera were determined by commercial Sheep IgG ELISA (Life 139 
Diagnostics Inc., West Chester, PA) as per manufacturer’s instructions.  Results were performed 140 
in duplicate and assays were repeated once. IgG is not transferred across the ovine placenta16,17 141 
resulting in hypogammaglobulinemia in presuckle lambs;18 therefore, in utero IgG levels can 142 
only have arisen by production by the fetus.  The reactivity of fetal antibodies for UP in the fetal 143 
sera was determined by immunoblot analysis as previously described for human studies.14  Total 144 
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protein equivalent to 30 µg of HPA5 per lane was separated by non-reducing polyacrylamide 145 
electrophoresis prior to electrophoretic transfer to nitrocellulose membranes.  A non-related UP 146 
serovar 6 strain (HPA61) was also included to examine the presence of pan-UP reacting 147 
antibodies.  Primary antibodies consisted of fetal or maternal sera at a final dilution of 1/100, 148 
subsequently detected with peroxidase-conjugated donkey anti-sheep antibodies (minimum 149 
species cross-reaction, Jackson ImmunoResearch UK).   150 
 151 
Statistical analyses. 152 
All values represent mean ± standard deviation (SD). Statistical analyses were performed using 153 
IBM SPSS Statistics for Windows, Version 20.0 (IBM Corporation, Armonk, NY.). Data were 154 
assessed for normality using Shapiro-Wilk tests. Normally distributed data, were tested either 155 
for significant mean differences by one-way ANOVA (for one factor) or where indicated by two 156 
factor ANOVA (e.g. age of serum source versus serum dilution), employing a critical value of 157 
0.05. Post-hoc analysis was performed with Bonferroni’s post-hoc test comparing only relevant 158 
groups to control. Between groups differences in non-parametric data were tested for 159 
significance with Kruskal-Wallis one-way ANOVA employing a critical value of 0.05. Multiple 160 
post-hoc comparisons for non-parametric data were performed using Rank-Sum tests with a 161 
critical value corrected for n multiple comparisons. Slope of the growth curve to analyse 162 
amniotic fluid titres for UP during experimental infection establishment, as well as Y-intercept 163 
and goodness of fit statistics, were performed by GraphPad Prism (La Jolla, CA) using non-164 
linear regression for exponential growth.  Correlation between the lysis of guinea pig 165 
erythrocytes and UP killing for each serum sample was performed as untransformed data 166 
(Pearson r=0.55; R2=0.30, p<0.05), however, the relationship between UP killing and sera 167 
concentration was found to be logarithmic, therefore, correlation between log10 killing and 168 
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serum lysis was much clearer and analysis on transformed data was more significant (Pearson 169 
r=0.93, R2=0.86; p<0.001) 170 
 171 
  172 
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RESULTS 173 
Ureaplasma-cidal activity of serum from adult sheep and preterm lambs.  174 
The capacity for sera collected from UP-naïve adult and preterm lambs from Group 1 (95 d GA) 175 
and Group 3 (125 d GA) were examined for its ability to kill the parental UP strain (HPA5) used 176 
for experimental intrauterine infection in the present study (Figure 1A).  Sera from uninfected 177 
adult sheep and preterm lambs was used to assess the innate immune killing and sera were 178 
confirmed to be devoid of anti-UP cross-reacting antibodies when tested by immunoblot (data 179 
not shown).  Adult sera at dilutions as low as 6.25% (v/v) was capable of killing all added UP. 180 
Sera from control 125 d GA lambs (Group 3) had reduced capacity to kill Ureaplasma, requiring 181 
8-fold more sera (50% (v/v) dilution) to achieve bactericidal activity observed for adult sheep 182 
(Figure 1A), whereas 50% (v/v) sera from control 95 d GA lambs (Group 1) had 100-fold lower 183 
bactericidal activity than 125 d GA lamb sera.  The kinetics of bactericidal activity in 50% (v/v) 184 
dilutions of sera were investigated by stopping complement function with EDTA at various time 185 
points for 95 d GA lamb sera and adult sheep sera (Figure 1B).  Despite the reduced bactericidal 186 
activity, preterm and adult sera showed identical killing kinetics, achieving most of the killing in 187 
10-15 minutes of incubation at 37oC (Figure 1B) and 95 d GA sera did not show any increase in 188 
bactericidal activity even if incubation was extended to 4 h (data not shown).  Bactericidal 189 
activity was found to be calcium dependent for both preterm and adult sera, as dilution in 10mM 190 
EGTA with additional Mg2+ showed no killing when complement activity was restricted to the 191 
alternative activation pathway (Figure 1B).  192 
 193 
Plasma titres of UP from UP-infected lambs of different gestational ages. 194 
In agreement with the in vitro bactericidal assays, the ability to culture UP from the cord blood 195 
of experimentally infected 95 d GA lambs was significantly greater than from 125 d GA lambs 196 
(Figure 2).  Lambs were surgically delivered at either: Group 2) 95 ± 2 d (25 d UP infection; 197 
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n=8); Group 4) 125 ± 2 d (42 d UP infection; n=8); or Group 5) 125 ± 2 d (10 d UP infection; 198 
n=10).  Two fetuses in Group 2 died prior to delivery and were excluded from the study.  199 
Amniotic fluid UP titres were independent of the length of infection or gestational age (range = 200 
5x106 - 3x107 infectious units/mL; data not shown). However, the identification of fetal UP 201 
bacteraemia varied greatly between groups.  None of the Group 4 animals had detectable UP 202 
bacteraemia; serum UP was detected in only one Group 5 fetus (500 infectious units/mL).  In 203 
contrast, 50% of Group 2 lambs (delivered at 95 d GA) had UP bacteraemia ranging from 500-204 
500,000 infectious units/mL (Table 1; Figure 2). None of the uninfected control animals (Groups 205 
1 and 3) had UP in either AF or fetal serum.  206 
 207 
Immunoblot analysis of antibody response in preterm lambs. 208 
Measurement of total serum IgG showed minimal antibody levels in all Groups, apart from 209 
Group 4, which were exposed to intraamniotic UP for 42 days prior to delivery at 125 d GA 210 
(Figure 3A). Immunoblot analysis was performed on all sera, but only those with elevated IgG 211 
levels in group 4 were found to have anti-UP antibody response against the parental infecting 212 
strain (HPA5).  Development of antibodies reacting to conserved antigens expressed by other 213 
non-infected strains was also evaluated by reactivity to an unrelated UP serovar 6 strain by 214 
immunoblot (Figure 3B). Despite elevated IgG levels in one of the Group 2 and one Group 5 215 
animal, these sera did not react with UP by immunoblot (Figure 3B). However, 66% of Group 216 
4 lambs (delivered at 125 d GA following 42 days UP infection) showed variable banding 217 
patterns by immunoblot, each recognising between 1 and 3 UP proteins.  Three of the lambs 218 
raised antibodies only expressed by the infecting strain HPA5 with a mass of 70-72 kDa, and 219 
three of the lambs recognised a 50 kDa mass protein only expressed by HPA5.  This 50 kDa 220 
band represents the major surface protein (multiple banded antigen; MBA) responsible for 221 
determining the serovar of the bacteria, and MBA reactivity for these sera was confirmed by 222 
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probing with a monoclonal antibody raised against the MBA (Figure 3B).  Two of the lambs 223 
also raised antibodies against a 42 kDa protein that was expressed by both the inoculating 224 
serovar 3 strain HPA5 and serovar 6 strain HPA61, suggesting reactivity to a conserved UP 225 
protein. 226 
 227 
Investigation of serum susceptibility of recovered plasma and amniotic fluid strains. 228 
UP strains recovered from the plasma of Group 2 lambs were examined to determine if they were 229 
less susceptible to serum killing than strains recovered from amniotic fluid from bacteraemic and 230 
non-bacteraemic lambs. Recovered isolates were separated into 3 groups: i) plasma-recovered 231 
isolates; ii) amniotic fluid recovered isolates from the same animals that had UP recovered from 232 
their plasma; and iii) amniotic fluid-recovered isolates from animals that did not have 233 
bacteraemia.  Susceptibility to 50% (v/v) adult sheep sera and 50% (v/v) 95 d GA sera from 234 
Group 2 animals are shown in Figure 4.  Isolates cultured directly from plasma were equally 235 
susceptible to sera as amniotic fluid-recovered isolates from matched or non-bacteraemic 236 
animals.  All recovered isolates were equally resistant to non-immune sera from control 95 d GA 237 
Group 1 animals, except (paradoxically) for one of the plasma-derived isolates (animal 115). 238 
 239 
Ureaplasma-cidal activity of sera from bacteraemic versus non-bacteraemic lambs. 240 
As no relative serum resistance was observed for isolates recovered from plasma compared to 241 
amniotic fluid, the capacity of the sera from bacteraemic and non-bacteraemic 95 d GA preterm 242 
lambs was compared for their individual capacity to kill the parental strain inoculated into the 243 
pregnant sheep.  Endogenous UP in bacteraemic sera was removed by filtration through a 0.22μm 244 
filter and removal of endogenous UP was confirmed by titration of filtered sera in Ureaplasma 245 
selective medium. The serum killing from the 95 d GA UP-infected animals in Group 2 was 246 
higher for non-bacteraemic than bacteraemic with one exception (Figure 5; lamb 116), which 247 
was also the lamb with the lowest detectable UP bacteraemia levels (Figure 2).  Further, it was 248 
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noted that the serum with the lowest UP killing activity was from the animal with the highest 249 
plasma titre of UP (lamb 115). These data suggested that killing capacity of the sera was directly 250 
linked to UP titres in the serum. 251 
 252 
Complement activity of sera from bacteraemic versus non-bacteraemic lambs. 253 
Complement activity (measured by lysis of guinea pig erythrocytes) was examined for the sera 254 
from UP-infected and uninfected 95 d GA lambs from Group 1.  Complement activity in serum 255 
from bacteraemic lambs was significantly lower at 50% and 25% dilutions than those found to 256 
have no UP in their plasma (non-bacteraemic) (p<0.001; Figure 6A).  However, the complement 257 
function of 125 dGA lambs was significantly greater than both of these, but still about 4-times 258 
less active relative to the complement activity in adult sheep sera (Figure 6A). The individual 259 
values for each of these animals can be found in supplementary figure 1, which shows the lowest 260 
complement function was observed in the lamb with the highest UP titre (lamb 115; 104 culture 261 
units/mL in plasma); in contrast, the highest complement activity for the bacteraemic group was 262 
found in the lamb with the lowest UP plasma titre (lamb 116; 10 culture units/mL in plasma; 263 
Figure 2).  Complement function for both bacteraemic and non-bacteraemic groups were 264 
representative of the range (30-95% lysis at 50% (v/v) sera dilution) observed from age matched 265 
(95 d GA) uninfected lambs from Group 1 (Figure 6B), indicating UP infection (or bacteraemia) 266 
did not influence the overall development of the complement system or consume complement 267 
through activation.  Furthermore, a correlation between Ureaplasma-cidal activity and 268 
complement activity in 95 d GA sera, irrespective of experimental UP infection, was found 269 
(Pearson r=0.93, R2=0.86; p<0.001; Figure 7).   270 
 271 
  272 
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DISCUSSION 273 
Neonates, particularly those born preterm (<37 weeks’ gestation), are frequently 274 
immunologically compromised and are more susceptible to morbidity and mortality due to 275 
infections.19  Previously, we developed a haemolysis assay to examine the complement function 276 
in sheep, as sheep erythrocytes are the common target for complement function in other species15 277 
and here we have extended use of our experimental intrauterine UP infection model to examine 278 
the role of complement insufficiency as a determining factor for development of in utero sepsis.  279 
Sepsis is a life-threatening response to infection leading to tissue and organ damage, often 280 
identified through the accompanying fever, tachycardia, tachypnea, and febrile morbidity.  Due 281 
to the collection of samples in our experimental infection model at Caesarean-section delivery 282 
under euthanasia conditions, measurement of temperature, breathing and heart rate could not be 283 
obtained in a meaningful manner.  Therefore, while we have examined bacteraemia as a surrogate 284 
marker of sepsis, it is important to note that sepsis (the body’s response to infection) in patients 285 
can occur in absence of bacteraemia and still responds to antibiotic treatment.  286 
 287 
The primary findings of this study are that in vitro and in vivo bactericidal capacity of fetal sheep 288 
sera diminished with increasing prematurity.  This finding was reflected by the increased 289 
incidence of bacteraemia detected in lambs experimentally infected with UP delivered at 95 d 290 
GA (50%) relative to 125 d GA (10%) lambs.  Within the 95 d GA cohort, the bactericidal serum 291 
activity was found directly correlated to the complement function in the serum (R2=0.30, p<0.05).  292 
However, the relationship between UP killing and sera concentration was found to be a 293 
logarithmic function and analysis of log10-transformed UP killing relative to complement 294 
functional assay values (represented by sera lysis of guinea pig erythrocyte targets) had a much 295 
stronger correlation (R2=0.86; p<0.001; Figure 7).  With one exception (animal 116), fetuses with 296 
bacteraemia were found to have lowest complement function compared to non-bacteraemic 297 
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fetuses; although animal 116 also had the lowest UP plasma titre (Figure 2) and the highest 298 
complement function within this this group (Supplementary Figure 1A).  The correlation between 299 
UP bactericidal activity and complement function was not influenced by experimental infection, 300 
suggesting that the natural variation in complement activity at 95 d GA determined whether UP 301 
infection in the amniotic fluid became systemic or not.  302 
 303 
Interestingly, measurement of IgG levels in control 95 and 125 d GA sera (Groups 1 & 3; Figure 304 
3), 1.6 ± 0.2 µg/ml and 2. 1 ± 0.5 µg/ml respectively, confirmed no transplacental maternal IgG 305 
transfer (maternal IgG levels were 14,400 ± 889 µg/ml) which has been speculated to be due to 306 
placental structure16,17 and lack of neonatal Fc expression in the placental tissues and blood 307 
vessels.  Therefore, measured IgG levels in the fetal sera in experimentally UP-infected animals 308 
could only have originated from the fetal immune system.  Only 1 animal from Group 2 (95 d 309 
GA) had elevated IgG (Figure 3A), but this sera failed to react with UP by immunoblot (Figure 310 
3B), and which was also the case for Group 5 (125 d GA, 10 d UP infection).  However, variable 311 
immune response was observed for Group 4 (125 d GA, 42 d UP infection), but again the highest 312 
IgG concentration (137) did not correspond to strongest recognition of multiple UP proteins by 313 
immunoblot (Figure 3). On the basis of these observations, it is would appear that complement, 314 
rather than adaptive immune response plays a critical role in protecting or resolving fetal UP 315 
bacteraemia in pregnancy.  Our inability to sample fetal blood prior to delivery prevented us from 316 
determining if the seropositive group represent those that were bacteraemic at earlier GA. The 317 
anti-UP antibodies can only be of fetal immune origin, as we have previously shown adult, but 318 
not fetal, sheep sera immunoglobulins cross-react with guinea pig erythrocytes15 and this was not 319 
detected in any of the sera from the preterm lambs (data not shown). 320 
 321 
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The HPA5 strain is susceptible to human serum killing in the absence of specific anti-UP 322 
antibodies.14  As with human serum studies with this strain, sheep serum bactericidal activity 323 
required the presence of calcium.  However, we are unable to determine if the bactericidal activity 324 
in sheep is mediated by the classical or lectin pathways (both require calcium), as we lack the 325 
reagents to differentially block these pathways as was performed for human sera.14  The increased 326 
presence of Ureaplasma spp. in the cord blood of human preterm neonates of increasing 327 
prematurity has also been identified in the previously published Alabama preterm study.4 328 
Furthermore, Cassell et al. found that Ureaplasma could be cultured from blood samples of 26% 329 
of 200 ventilated preterm neonates studied, showing that Ureaplasma bacteraemia is prevalent in 330 
this patient group.8 331 
Sheep models have recently been developed to investigate hypoxic delivery complications and 332 
intrauterine inflammation induced by microbial infection or exposure to lipopolysaccharides.20-333 
26  None of these studies, however, has investigated the contribution of the complement system 334 
to disease pathogenesis or to the role of complement in controlling systemic infection, largely 335 
due to the current lack of reagents to measure and manipulate the sheep complement system. The 336 
present study thus represents a significant advance in our understanding of the pathophysiology 337 
of fetal bacteraemia in the setting of preterm birth. 338 
 339 
In conclusion, experimental intrauterine UP infection establishes stable amniotic fluid levels that 340 
remain stable for weeks following the infection.27  Highlighting the importance of 341 
gestation/complement function on fetal response to challenge, UP was detected in the cord blood 342 
of 50% of fetuses infected at 70 d GA and delivered at 95 d GA (Group 2), but only in 10% of 343 
lambs infected at 115 d GA and delivered at 125 d GA (Group 5).  No bacteraemia was observed 344 
in lambs infected at 80 d GA and delivered at 125 d GA (Group 4), but this was the only group 345 
to show a UP-specific antibody response. Interestingly, a range of functional complement activity 346 
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was observed in uninfected 95 d GA preterm lambs, indicating that development of the 347 
complement system is variable in the normal population and is not influenced by intrauterine UP 348 
infection.  In addition to advancing our understanding of fetal responses to UP infection, our 349 
results also suggest that a familial history of complement deficiency may increase the risk of fetal 350 
UP infection in pregnancy, concomitant with an increased risk of preterm birth and adverse 351 
neonatal outcomes. 352 
 353 
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FIGURE LEGENDS. 473 
Figure 1.  (A) Titration of Ureaplasma-cidal activity in non-immune sera.  UP killing by 474 
diluted sera from adult sheep (closed circle), 125 d GA preterm lambs (open square) and 95 d 475 
GA preterm lambs (grey triangle) following 1 h incubation at 37oC.  Killing determined by 476 
relative decrease in UP titre compared to incubation with matched heat-inactivated sera controls.  477 
Each point represents average and standard deviation of sera from 4 separate animals (performed 478 
in duplicate). Results were repeated in 2 duplicate experiments.  479 
(B) UP killing kinetics of non-immune adult sheep and 95 d GA sera.  Sera diluted to 50% 480 
(v/v) in calcium and magnesium containing buffer (adult = closed circle, 95 d GA =closed 481 
square) were incubated with UP for various times before blocking further complement 482 
activation with addition of EDTA prior to titration of surviving UP.  No serum killing of UP 483 
was observed if sera were diluted in alternative pathway buffer containing EGTA and 484 
magnesium (adult = open circle, 95 d GA = open square). Each point represents average and 485 
standard error of sera from 4 separate uninfected animals, killing calculated by decreased titre 486 
relative to UP titre following incubation with matched heat-inactivated sera. Data from one of 487 
three replicated experiments shown. Significant differences were found between all points by 488 
two factor ANOVA (dilution and age of serum source/addition of EGTA) and Bonferroni post-489 
hoc analysis found significant reduction relative to adult serum killing for all data points after 5 490 
minutes incubation. Significant differences were found by two-factor ANOVA (dilution and age 491 
of donor) and Bonferroni post-hoc analysis found significant reduction relative to adult serum 492 
killing for all points but 125 d GA sera at 50% dilution.  p<0.01 = **; p<0.001 = *** 493 
Figure 2. UP titres in cord plasma at delivery.  GA at delivery and total length of UP infection 494 
is indicated for each group.  Each point represents the average as determined in triplicate. Data 495 
points for lambs 115 and 116 are separately identified for correlation purposes in other figures.  496 
Results were repeated in 2 duplicate experiments. 497 
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Figure 3.  (A) IgG concentration in 95 d and 125 d GA lambs.  ELISA determination of 498 
sheep IgG levels in sera from uninfected control lambs (Groups 1 and 3), compared to 499 
experimentally UP-infected lambs.  Lambs 121 (Group 2) and 235 (Group 5) are identified as 500 
they have elevated IgG levels, but do not react with UP by immunoblot in (B). Results were 501 
repeated once. 502 
(B)  Detection of anti-UP antibodies in fetal sera from infected lambs.  Purified whole UP 503 
cultures from the infecting serovar 3 strain (HPA5) and separate serovar 6 strain (HPA61) were 504 
separated by non-reducing SDS-PAGE and probed with fetal sera to detect immunoreactive 505 
bands by immunoblot analysis.  Two infected lambs from Group 4 failed to raise specific anti-506 
UP immune response (130 and 132) as well as all of the animals in Group 2 and 4 (only sera with 507 
elevated IgG from Groups 2 (121) and Group 4 (235) are shown).  Four lambs in Group 4 raised 508 
an antibody response to proteins unique to the infecting strain and two of these lambs (136 and 509 
137) also raised cross-reacting antibodies that also recognised strain HPA61 which is a serovar 510 
6 isolate.  The MBA isoforms for both strains are identified by mouse monoclonal antibody 6523. 511 
Representative results of 3 repeat experiments shown. 512 
Figure 4. Serum susceptibility of UP recovered from plasma or amniotic fluid.  Recovered 513 
strains were incubated for 30 min with 50% (v/v) adult sheep (A) or 50% (v/v) 95 d GA preterm 514 
lamb sera (B).  Pooled sera from uninfected animals was used and each point was determined in 515 
duplicate.  Representative data shown from 3 repeated experiments. Killing calculated as 516 
decreased titre relative to UP titre following incubation with matched heat-inactivated sera 517 
controls.  One way ANOVA analysis found no difference between these groups. 518 
Figure 5.  Ureaplasma-cidal activity from bacteraemic, non-bacteraemic, and uninfected 95 519 
d GA lambs. Serum killing of HPA5 by 50% (v/v) sera from bacteraemic (plasma UP), non-520 
bacteraemic (no plasma UP) and uninfected 95 d GA preterm lambs.  Each point represents the 521 
average of 3 separate killing assays (each performed in duplicate). Killing calculated as decreased 522 
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titre relative to UP titre following incubation with matched heat-inactivated sera. Individual 523 
points for lambs 115 and 116 are identified. 524 
Figure 6.  Functional complement activity as determined by guinea pig erythrocyte lysis 525 
assay after 30 min by diluted sera.  A.  Complement activity for uninfected adult sheep (closed 526 
circles) and late preterm (125 dGA; closed squares) lamb sera are shown relative to complement 527 
function in sera from UP infected 95 dGA lambs with bacteraemia (+; open circles) and without 528 
bacteraemia (-; open squares). Two factor ANOVA (age of sera source and dilution) with 529 
Bonferroni post-hoc analysis found significantly increased complement function relative to 530 
infected 95 dGA lambs with bacteraemia for all points shown (p<0.001 = ***).  Each point 531 
represents mean of triplicate values for N=4 animals per group. B. For comparison a wide range 532 
of complement function was observed in control sera from uninfected lambs at 95 dGA, 533 
indicating UP bacteraemia doesn’t reduce complement activity. Each point determined in 534 
triplicate, unique identifiers for each lamb are given. Results were repeated in 2 duplicate 535 
experiments. 536 
Figure 7.  Correlation between complement activity and Ureaplasma-cidal activity.  537 
Complement activity shown as haemolysis of 50% (v/v) sera at 30 min relative to fold-killing of 538 
50% (v/v) sera at 30 min at 37oC. Data for infected lambs with bacteraemia (plasma UP) or 539 
without bacteraemia (no plasma UP) and uninfected preterm lambs are separately identified.  540 
Each point determined in triplicate.  Correlation for log10 transformed killing data relative to lysis 541 
(Pearson r=0.93; R2=0.86, p<0.001) shown for untransformed data. 542 
